Research Article
Evaluating Drug Risk Using GAN and SMOTE Based on CFDA’s Spontaneous Reporting Data
Table 4
Evaluation metrics based on the test set.
| | Classifier | Label | Precision | Recall | F1 | Accuracy (%) |
| | Model 1 (RF) | 0 | 0.85 | 0.99 | 0.92 | | | 1 | 0.50 | 0.03 | 0.06 | 84.44 | | 2 | 0.00 | 0.00 | 0.00 | | | Macro-avg | 0.45 | 0.34 | 0.32 | | | Weighted-avg | 0.78 | 0.84 | 0.78 | |
| | Model 2 (SMOTE + RF) | 0 | 0.91 | 0.85 | 0.88 | | | 1 | 0.91 | 0.94 | 0.92 | 91.99 | | 2 | 0.94 | 0.97 | 0.96 | | | Macro-avg | 0.92 | 0.92 | 0.92 | | | Weighted-avg | 0.92 | 0.92 | 0.92 | |
| | Model 3 (FS_GAN + SMOTE + RF) | 0 | 0.93 | 0.96 | 0.94 | | | 1 | 0.98 | 0.94 | 0.96 | 96.25 | | 2 | 0.98 | 0.98 | 0.98 | | | Macro-avg | 0.96 | 0.96 | 0.96 | | | Weighted-avg | 0.96 | 0.96 | 0.96 | |
|
|